Psychiatric Comorbidities in Children with Attention Deficit Hyperactivity Disorder
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Pediatric Drugs
- Vol. 5 (11) , 741-750
- https://doi.org/10.2165/00148581-200305110-00003
Abstract
Attention deficit hyperactivity disorder (ADHD) is frequently comorbid with a variety of psychiatric disorders. These include oppositional defiant disorder and conduct disorder (CD), as well as affective, anxiety, and tic disorders. ADHD and ADHD with comorbid CD appear to be distinct subtypes; children with ADHD/CD are at higher risk of antisocial personality and substance abuse as adults. Stimulants are often effective treatments for aggressive or antisocial behavior in patients with ADHD, but mood stabilizers or atypical antipsychotics may be used to treat explosive aggressive outbursts. Response to stimulants is not affected by comorbid anxiety, but children with ADHD/anxiety disorder may show greater benefit from psychosocial interventions than those with ADHD alone. The degree of prevalence of major depressive disorder (MDD) and bipolar disorder among children with ADHD is controversial, but a subgroup of severely emotionally labile ADHD children who present serious management issues for the clinician clearly exists. Antidepressants may be used in conjunction with stimulants to treat MDD, while mood stabilizers and atypical antipsychotics are often required to treat manic symptoms or aggression. After resolution of the manic episode, stimulant treatment of the comorbid ADHD may be safely undertaken. Recent research suggests that stimulants can be safely used in children with comorbid ADHD and tic disorders, but the addition of anti-tic agents to stimulants is often necessary. Clinicians who work with patients with ADHD should be prepared to deal with a wide range of emotional and behavioral problems beyond the core symptoms of inattention and impulsivity/hyperactivity.Keywords
This publication has 94 references indexed in Scilit:
- Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2002
- Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response StudyPediatrics, 2001
- Empirically supported psychosocial treatments for attention deficit hyperactivity disorderJournal of Clinical Child Psychology, 1998
- Prevalence of ADHD and comorbid disorders among elementary school children screened for disruptive behaviorJournal of Abnormal Child Psychology, 1996
- School Observations of Children with Attention-Deficit Hyperactivity Disorder and Comorbid Tic DisorderJournal of Developmental & Behavioral Pediatrics, 1995
- An Epidemiological Study of Disorders in Late Childhood and Adolescence—I. Age‐ and Gender‐Specific PrevalenceJournal of Child Psychology and Psychiatry, 1993
- Fluoxetine and Methylphenidate in Combination for Treatment of Attention Deficit Disorder and Comorbid Depressive DisorderJournal of Child and Adolescent Psychopharmacology, 1993
- Covert antisocial behavior in boys with attention-deficit hyperactivity disorder: External validation and effects of methylphenidate.Journal of Consulting and Clinical Psychology, 1992
- Anitdepressants in the Treatment of Child and Adolescent PsychopathologyJournal of Clinical Child Psychology, 1991
- Separation of DSM-III attention deficit disorder and conduct disorder: evidence from a family-genetic study of American child psychiatric patientsPsychological Medicine, 1991